Park Avenue Securities’s Zimmer Biomet ZBH Stock Holding History

Park Avenue Securities’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	4,676 -294	-6%	-$25.8K	﹤0.01%	1392
2026 Q1	$449K	Buy	4,970 +325	+7%	+$29.8K	﹤0.01%	1153
2025 Q4	$418K	Sell	4,645 -1,036	-18%	-$98.2K	﹤0.01%	1175
2025 Q3	$560K	Sell	5,681 -353	-6%	-$35K	﹤0.01%	1129
2025 Q2	$550K	Buy	+6,034	New	+$583K	0.01%	1028
2025 Q1	–	Sell	-5,300	Closed	-$560K	–	1552
2024 Q4	$560K	Buy	5,300 +51	+1%	+$5.47K	0.01%	1023
2024 Q3	$567K	Buy	5,249 +3,219	+159%	+$351K	0.01%	927
2024 Q2	$220K	Sell	2,030 -643	-24%	-$75.8K	﹤0.01%	1291
2024 Q1	$353K	Sell	2,673 -3,181	-54%	-$397K	﹤0.01%	1107
2023 Q4	$712K	Sell	5,854 -3,439	-37%	-$384K	0.01%	759
2023 Q3	$1.04M	Buy	+9,293	New	+$1.18M	0.02%	544
2023 Q1	–	Sell	-5,523	Closed	-$704K	–	1184
2022 Q4	$704K	Buy	5,523 +4	+0.1%	+$464	0.01%	657
2022 Q3	$577K	Buy	5,519 +142	+3%	+$15.6K	0.01%	656
2022 Q2	$565K	Buy	5,377 +196	+4%	+$23.3K	0.01%	676
2022 Q1	$663K	Buy	+5,181	New	+$625K	0.01%	624

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Park Avenue Securities's ZBH Position: Q2 2026 in Review

Park Avenue Securities reduced its Zimmer Biomet (ZBH) stake by 5.9% in Q2 2026, selling an estimated $25.8K and leaving 4,676 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Park Avenue Securities first reported a position in ZBH in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.04M in Q3 2023. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Park Avenue Securities held 4,676 shares of Zimmer Biomet worth $403K as of Q2 2026.
Park Avenue Securities sold 294 Zimmer Biomet shares in Q2 2026, an estimated $25.8K.
Zimmer Biomet made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1392 holding.
Park Avenue Securities first reported a position in Zimmer Biomet in Q1 2022 and has held it in 15 quarters since.
Park Avenue Securities's Zimmer Biomet position peaked at $1.04M in Q3 2023.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.